Upcoming Webinar
Instrumentl Fall Launch: Grant Work, Leveled Up.
Thu, Oct 29
or
Wed, Nov 4
@ 2PM ET
Why Instrumentl
Full Cycle Grant Platform
By Customer
Featured
$1.1m More Per Year
The Instrumentl Impact Report
Explore
Learn
Connect
Find the perfect Grants for Capital Funding in Washington on Instrumentl. 10,000+ Grants for Capital Funding in Washington in the United States.
10,000+
Available grants
$2.85B
Total funding
$5K
Median grant
Skip the search. Get matched with grants that fit your non-profit.
Smart recommendations based on your profile — in minutes.
Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows
Catalyzing Innovation through Partnerships
At its core, Grand Challenges catalyzes bold innovation through partnership - bringing together funders, researchers, implementers, and public health leaders to solve complex global challenges. This multi-partner initiative reflects the Grand Challenges ethos, leveraging complementary expertise and investments to accelerate accessible genomic sequencing solutions for low- and middle-income Countries.
About this Challenge
This Grand Challenge is co-funded by the Gates Foundation, and the Temasek Foundation, and will be managed by the United Nations Foundation. This Grand Challenge is implemented in collaboration with a network of global and regional partners, including International Pathogen Surveillance Network (IPSN), hosted by the WHO Hub for Pandemic and Epidemic Intelligence, the Africa Pathogen Genomics Initiative (Africa PGI), and the Asia Pathogen Genomics Initiative (Asia PGI) as regional technical and public-health partners. This RFP aims to accelerate the development of affordable, scalable, and operationally simple sequencing solutions, enabling routine use of genomics for public health in low- and middle-income countries (LMICs).
Award Structure and Funding Level
To accommodate different stages of innovation maturity, this RFP supports a tiered award structure, with funding levels and expectations aligned to the readiness and scope of the proposed work. Indicative award categories are:
For more mature concepts aimed at workflow refinement, performance optimization, and generation of proof-of-concept and validation data in relevant public-health use cases in LMICs.
About the Emporia Community Foundation
Our Mission
To connect caring people with causes that build stronger communities within the Emporia area which includes Chase, Coffey, Greenwood, Lyon, Morris, Osage and Wabaunsee counties.
Never Let Go Fund
The purpose of the Never Let Go Fund is to provide funds to qualified individuals to cover expenses related to the treatment of childhood cancer. Grant requests will be considered for children under the age of 18.
Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows
Catalyzing Innovation through Partnerships
At its core, Grand Challenges catalyzes bold innovation through partnership - bringing together funders, researchers, implementers, and public health leaders to solve complex global challenges. This multi-partner initiative reflects the Grand Challenges ethos, leveraging complementary expertise and investments to accelerate accessible genomic sequencing solutions for low- and middle-income Countries.
About this Challenge
This Grand Challenge is co-funded by the Gates Foundation, and the Temasek Foundation, and will be managed by the United Nations Foundation. This Grand Challenge is implemented in collaboration with a network of global and regional partners, including International Pathogen Surveillance Network (IPSN), hosted by the WHO Hub for Pandemic and Epidemic Intelligence, the Africa Pathogen Genomics Initiative (Africa PGI), and the Asia Pathogen Genomics Initiative (Asia PGI) as regional technical and public-health partners. This RFP aims to accelerate the development of affordable, scalable, and operationally simple sequencing solutions, enabling routine use of genomics for public health in low- and middle-income countries (LMICs).
Award Structure and Funding Level
To accommodate different stages of innovation maturity, this RFP supports a tiered award structure, with funding levels and expectations aligned to the readiness and scope of the proposed work. Indicative award categories are:
For concepts with preliminary feasibility evidence that are ready to advance from prototype toward an integrated workflow—optimizing performance, broadening assay or pathogen coverage, and generating more robust cost-reduction and performance data.
Gilead Sciences
At Gilead, we are relentlessly committed to advancing transformative therapies for the most serious diseases, delivering an exponentially positive impact on health.
For more than three decades, we have combined scientific rigor with a deep sense of purpose to improve health outcomes and reimagine care. Our work spans more than 35 countries with a focus on three therapeutic areas: virology, oncology, and inflammation, where unmet medical needs remain greatest.
From individual patients to whole populations, we’re committed to delivering healthier futures for people and communities worldwide.
Our Mission: To discover, develop and deliver innovative therapeutics for people with life-threatening diseases.
HIV Prevention NOVA 2026
Program Description
Gilead Sciences invites research proposals that advance the evidence base for innovative and scalable models of delivery for long-acting (LA) HIV pre-exposure prophylaxis (PrEP) in the United States.
This Topic of Interest (TOI) is focused on care delivery models implemented in non-traditional settings, defined as clinical and non-clinical environments where PrEP services are not routinely provided. Emphasis is placed on approaches that reflect real-life practice and address gaps in current PrEP delivery infrastructure.
Persistent inequities in PrEP uptake in the U.S. suggest that expanding availability within traditional clinical settings alone is unlikely to reach all populations with unmet PrEP need.1,2 Rigorous implementation studies in non-traditional settings where PrEP services are not routinely provided are needed to evaluate whether these models can reduce access barriers and improve equitable reach among individuals who may benefit from PrEP.2,3,4
The goal of this TOI is to generate practical, decision-relevant evidence that informs how LA PrEP can be implemented, scaled, and sustained in real-life U.S. settings.
Looking for grants for capital funding in Washington?
Read more about each grant below or start your 14-day free trial to see all grants for capital funding in Washington recommended for your specific programs.
How common are grants in this category?
Common — grants in this category appear regularly across funding sources.
Over the past year, when are grant deadlines typically due for grants for Capital Funding in Washington?
Most grants are due in the first quarter.
What's the typical grant amount funded for Grants for Capital Funding in Washington?
Grants are most commonly $25,000.
What's the typical amount funded for Washington?
Grants are most commonly $253,657.
What's the total number of grants in Grants for Capital Funding in Washington year over year?
In 2024, funders in Washington awarded a total of 54,367 grants.
Among all the Grants for Capital Funding in Washington given out in Washington, the most popular focus areas that receive funding are Education, Human Services, and Philanthropy, Voluntarism & Grantmaking Foundations.
1. Education
2. Human Services
3. Philanthropy, Voluntarism & Grantmaking Foundations
How is funding for Grants for Capital Funding in Washington changing over time?
Funding has increased by 5.42%.
How does grant funding vary by county?
King County, Pierce County, and Snohomish County receive the most funding.
| County | Total Grant Funding in 2024 |
|---|---|
| King County | $10,608,506,165 |
| Pierce County | $534,186,995 |
| Snohomish County | $442,338,004 |
| Clark County | $261,140,531 |
| Spokane County | $215,289,506 |